Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Industrivärden A INDUA Apr 15, 2021 335.20 +0.96   
 Industrivärden C INDUC Apr 15, 2021 319.40 +0.73   
 Indutrade INDT Apr 15, 2021 219.80 +1.38   
 Infant Bacterial Therapeutics B IBTB Apr 15, 2021 100.40 -0.79   
 Infracom INFRA Apr 15, 2021 22.90 -0.43   
 Infrea INFREA Apr 15, 2021 39.20 -0.76   
 Infront INFROO Apr 15, 2021 29.90 0.00   
 Inhalation Sciences ISAB Apr 15, 2021 10.00 +1.01   
 Inission B INISSB Apr 15, 2021 114.50 +2.69   
 Initiator Pharma INIT Apr 15, 2021 4.68 -4.49   
 Insplorion INSP Apr 15, 2021 25.25 -2.32   
 Insr Insurance Group INSRO Apr 15, 2021 0.53 0.00   
 Instalco INSTAL Apr 15, 2021 349.80 +0.29   
 Integrum B INTEGB Apr 15, 2021 54.00 +8.00   
 International Petroleum Corp. IPCO Apr 15, 2021 26.98 -0.74   
 Interoil Exploration and Production IOXO Apr 15, 2021 1.40 0.00   
 Intervacc IVACC Apr 15, 2021 89.40 +3.11   
 Intrum INTRUM Apr 15, 2021 290.00 +0.21   
 Invajo Technologies INVAJO Apr 15, 2021 5.24 -1.13   
 Invent Medic IMS Apr 15, 2021 5.90 +7.27   
 Investor A INVEA Apr 15, 2021 719.00 +0.45   
 Investor B INVEB Apr 15, 2021 719.30 +0.47   
 INVISIO IVSO Apr 15, 2021 206.40 -1.53   
 Inwido INWI Apr 15, 2021 145.00 +1.83   
 Inzile INZILE Apr 15, 2021 39.00 0.00   
 Irisity IRIS Apr 15, 2021 63.70 -1.85   
 IRLAB Therapeutics A IRLABA Apr 15, 2021 41.00 -1.91   
 IRRAS IRRAS Apr 15, 2021 6.28 -0.48   
 Isofol Medical ISOFOL Apr 15, 2021 18.20 +9.11   
 ISR Immune System Regulation Holding AB ISR Apr 15, 2021 4.48 +2.99   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK